These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34215999)

  • 1. Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection.
    Misgar RA; Rasool A; Wani AI; Bashir MI
    J Endocrinol Invest; 2021 Dec; 44(12):2855-2856. PubMed ID: 34215999
    [No Abstract]   [Full Text] [Related]  

  • 2. Langerhans cell histiocytosis.
    Kumar M; Menon AS
    Indian J Med Res; 2018 Sep; 148(3):351-352. PubMed ID: 30425231
    [No Abstract]   [Full Text] [Related]  

  • 3. Central diabetes insipidus: beware of Langerhans cell histiocytosis!
    Brys ADH; Vermeersch S; Forsyth R; Velkeniers B; Bravenboer B
    Neth J Med; 2018 Dec; 76(10):445-449. PubMed ID: 30569891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 Comirnaty vaccine in adolescents: A case report.
    Partenope C; Pedranzini Q; Petri A; Rabbone I; Prodam F; Bellone S
    Front Endocrinol (Lausanne); 2023; 14():1166953. PubMed ID: 37143723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurogenic diabetes insipidus.
    Jane JA; Vance ML; Laws ER
    Pituitary; 2006; 9(4):327-9. PubMed ID: 17080264
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of suspected IgG4-related hypophysitis presented with panhypopituitarism and central diabetes insipidus].
    Kubo H; Ohtsubo H; Shiraoka A; Watanabe M; Kyoraku I; Okamoto K
    Rinsho Shinkeigaku; 2024 Jun; 64(6):398-402. PubMed ID: 38797688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of neurogenic diabetes insipidus.
    Chanson P; Salenave S
    Ann Endocrinol (Paris); 2011 Dec; 72(6):496-9. PubMed ID: 22071315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ISCHEMIC PITUITARY APOPLEXY, HYPOPITUITARISM AND DIABETES INSIPIDUS: A TRIAD UNIQUE TO NECROTIZING HYPOPHYSITIS.
    Ćaćić M; Marinković J; Kruljac I; Perić B; Čerina V; Stipić D; Pažanin L; Pećina HI; Vrkljan M
    Acta Clin Croat; 2018 Dec; 57(4):768-771. PubMed ID: 31168215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary dysfunction in granulomatosis with polyangiitis.
    Vega-Beyhart A; Medina-Rangel IR; Hinojosa-Azaola A; Fernández-Barrio M; Vargas-Castro AS; García-Inciarte L; Guzmán-Pérez A; Torres-Victoria TR; Martínez-Sánchez FD; Pérez-Guzmán MC; Hinojosa-Amaya JM; León-Suárez A; Gómez-Sámano MA; Gómez-Pérez FJ; Cuevas-Ramos D
    Clin Rheumatol; 2020 Feb; 39(2):595-606. PubMed ID: 31446541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When polyuria does not stop: a case report on an unusual complication of hantavirus infection.
    Schwab S; Lissmann S; Schäfer N; Isaak A; Klingmüller D; Attenberger U; Eis-Hübinger AM; Hofmann J; Strassburg CP; Lutz P
    BMC Infect Dis; 2020 Sep; 20(1):713. PubMed ID: 32993515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central diabetes insipidus caused by a pituitary stalk germinoma resembling infundibuloneurohypophysitis.
    Dias D; Vilar H; Passos J; Leite V
    BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32912882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of anti-rabphilin-3A antibodies for diagnosing central diabetes insipidus in the third trimester of pregnancy.
    Sakurai K; Yamashita R; Niituma S; Iwama S; Sugimura Y; Arihara Z; Takahashi K
    Endocr J; 2017 Jun; 64(6):645-650. PubMed ID: 28420857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia.
    Christ-Crain M; Hoorn EJ; Sherlock M; Thompson CJ; Wass JAH
    Eur J Endocrinol; 2020 Jul; 183(1):G9-G15. PubMed ID: 32380474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmopressin as a Novel Long-Term Treatment in Postural Tachycardia Syndrome Patients with Polyuria.
    Seeley MC; Thynne TR; Braund WJ; Worthley DL; Gallagher C; Sanders P; Lau DH
    Am J Med; 2021 Sep; 134(9):e486-e487. PubMed ID: 33865825
    [No Abstract]   [Full Text] [Related]  

  • 15. Comments on "Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study"--efficacy and safety of orally disintegrating desmopressin tablets in patients with central diabetes insipidus.
    Kamoi K
    Endocr J; 2013; 60(9):1115. PubMed ID: 23863202
    [No Abstract]   [Full Text] [Related]  

  • 16. Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?
    Ishay A; Shacham EC
    BMC Endocr Disord; 2023 Feb; 23(1):47. PubMed ID: 36810011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus.
    Almutlaq N; Eugster EA
    J Pediatr; 2021 Dec; 239():228-230. PubMed ID: 34487771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
    Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with sublingual desmopressin in two infants with hydranencephaly and central diabetes insipidus].
    Marín GR; Baspineiro B; Vilca I
    Arch Argent Pediatr; 2018 Feb; 116(1):e93-e97. PubMed ID: 29333830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Central diabetes insipidus].
    Oiso Y
    Nihon Rinsho; 2006 May; Suppl 1():187-9. PubMed ID: 16776123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.